Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia

By sjmartinez • February 19, 2025

Bergersen KV, Zheng Y, Rossetti M, Ruffin F, Pickering H, Parmar R, Sunga G, Chan LC, Gjertson D, Fowler VG, Yeaman MR, Reed EF; MRSA Systems Immunobiology Group. Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia. BMC Infect Dis. 2025 Feb 18;25(1):231. doi: 10.1186/s12879-025-10620-3. PMID: 39966757.

Tags: Clinical phenotypes, Cytokine signatures, Harbor UCLA, MRSA, persistence, Publications, Pulmonary, Critical Care & Sleep Medicine, Staphylococcus aureus

The history and future of online hemodiafiltration and online solutions in North America

Leduc C, Tomisawa N, Ronco C, Kalantar-Zadeh K. The history and future of online hemodiafiltration and online solutions in North America. Curr Opin Nephrol Hypertens.[...]

Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial

Luetkemeyer AF, Chew KW, Lacey S, Hughes MD, Harrison LJ, Daar ES, Eron J, Fletcher CV, Greninger AL, Hessinger D, Li JZ, Mailhot D, Wohl[...]

Greening Infection Prevention and Control: Multifaceted Approaches to a Sustainable Future

Lee PS, Frantzis I, Abeles SR. Greening Infection Prevention and Control: Multifaceted Approaches to a Sustainable Future. Open Forum Infect Dis. 2024 Jul 3;12(2):ofae371. doi:[...]